SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject8/3/2004 3:07:11 PM
From: tuck   of 897
 
BSCP decides to take its lumps on QLTI short. It was based on the thesis that Visudyne sales would slow, but that looks erroneous for the time being. Uncertainty about the ATRX munch and seasonal biotech weakness have hurt it a bit, but I don't expect the summer to get much worse. Closing at $16.75, about a 45% loss. The portfolio as a whole has nevertheless returned an annualized 20%, roughly, in three years. Not bad, two were down, one was up.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News